Mikayla Hancock, a 29-year-old office worker, was diagnosed with stage 4 ovarian cancer after experiencing a series of subtle symptoms for over a year that doctors initially dismissed. The aggressive tumor, which had been growing for an estimated one to four years, measured 23cm by the time of its discovery and had spread to her lungs, also compressing her bladder.
Her initial symptom, constipation occurring every few months, began in August 2025. She was advised to increase her fiber intake and hydration. When this did not resolve the issue, doctors suggested a food intolerance, prompting Hancock to keep a food diary. Subsequently, she developed a sharp, intermittent pelvic pain after using the toilet, which was attributed to a strained pelvic muscle. Despite these recurring issues, Hancock, who had no family history of cancer, initially accepted the medical explanations.
During a trip to Fiji in early March, further symptoms emerged, including a noticeable increase in the frequency of urination, a feeling of fullness after eating minimal amounts, and acid reflux. Upon returning home, she developed a sore throat, severe back pain, persistent diarrhea, cramping, and nausea, which were initially linked to a COVID-19 recovery. However, her condition worsened, with her abdomen becoming distended and painful, leading her to seek emergency medical attention at her mother's insistence.
At the hospital, medical staff noted her elevated heart rate and severe gastrointestinal distress. Initial tests and assessments for various conditions, including tropical diseases and appendicitis, provided no diagnosis. A subsequent CT scan revealed a large mass in her abdomen. Within hours, she received the diagnosis of ovarian cancer from a gynecologist, with further scans indicating spread to her lungs. Hancock expressed shock, stating she had not anticipated such a diagnosis when presenting with stomach issues.
Her tumor markers, blood tests typically used to detect ovarian cancer, had remained normal, complicating the diagnostic process. Due to the aggressive nature of the cancer, chemotherapy commenced almost immediately. Despite initial success in shrinking the tumor to approximately 10cm, Hancock experienced complications including a bowel obstruction and septic shock, requiring a stay in intensive care. After five and a half weeks in the hospital, she was discharged to continue outpatient chemotherapy. She has since completed treatment and is preparing for surgery to remove residual tumor particles. Doctors have indicated that the remaining cancer is treatable, offering hope for recovery despite the stage 4 diagnosis.
Hancock shared her experience to encourage other women to advocate for their health. She emphasized that ovarian cancer is often a "silent killer" due to vague or dismissed symptoms, and urged women to push for further investigation if they are unsatisfied with initial medical assessments, highlighting the critical role of early detection in improving outcomes.